How Do I Say It? Patient-Provider Communication in Diffuse Large B-Cell Lymphoma Care
Listen now
Description
Effective communication between patients and healthcare providers is crucial to facilitate shared decision-making and meaningful dialogue that supports improved patient outcomes in diffuse large B-cell lymphoma (DLBCL) care. In this episode, CANCER BUZZ speaks with Jean Louise Koff, MD, MSc, associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine in Atlanta, Georgia, about fostering trust, rapport, and collaboration in the patient-provider relationship. “I think empathy is a key part of establishing a relationship between a provider and a patient. [It] helps the patient feel safe when they’re dealing with what can be a very stressful and frightening situation...A phrase that I like to use: ‘Our care team is going to take care of you. We are here for you during this diagnosis, and we’re going to take care of you as you move through your care plan.’” — Jean Louise Koff, MD, MSc   Jean Louise Koff, MD, MSc Associate Professor Department of Hematology and Oncology Winship Cancer Institute Emory University School of Medicine Atlanta, GA   This video podcast was produced in partnership with the Leukemia and Lymphoma Society and made possible by support from Abbvie, Genmab, and Genentech. Resources ·       Reframing the Conversation: Effective Practices for Diffuse Large B-Cell Lymphoma - ACCC ·       DLBCL Communication Roadmap - ACCC
More Episodes
The range of frontline therapy options for mantle cell lymphoma can influence subsequent treatment choices for patients with relapsed or refractory disease. Providers must determine initial treatment based on individual patient characteristics, while also factoring in future treatment options. In...
Published 09/19/24
Advancements in treatment combined with a multimodal approach are improving outcomes for patients with head and neck cancer. However, the unique challenges of a head and neck cancer diagnosis and its treatment side effects—such as speech and communication difficulties as well as negative effects...
Published 09/12/24
Published 09/12/24